Why do we have so few effective drugs for irritable bowel syndrome? A European perspective

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	436-437
Number of pages	2
Journal	Nature Clinical Practice Gastroenterology and Hepatology
Volume	2
Issue number	10
DOIs	https://doi.org/10.1038/ncpgasthep0292
State	Published - Oct 1 2005

ASJC Scopus subject areas

@article{27b7f28ac6ec4240b358a08936466575,

title = "Why do we have so few effective drugs for irritable bowel syndrome? A European perspective",

author = "Quigley, {Eamonn Martin}",

year = "2005",

month = oct,

day = "1",

doi = "10.1038/ncpgasthep0292",

language = "English (US)",

volume = "2",

pages = "436--437",

journal = "Nature Clinical Practice Gastroenterology and Hepatology",

issn = "1743-4378",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Why do we have so few effective drugs for irritable bowel syndrome? A European perspective

AU - Quigley, Eamonn Martin

PY - 2005/10/1

Y1 - 2005/10/1

UR - http://www.scopus.com/inward/record.url?scp=27744444541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27744444541&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0292

DO - 10.1038/ncpgasthep0292

M3 - Review article

C2 - 16224458

AN - SCOPUS:27744444541

VL - 2

SP - 436

EP - 437

JO - Nature Clinical Practice Gastroenterology and Hepatology

JF - Nature Clinical Practice Gastroenterology and Hepatology

SN - 1743-4378

IS - 10

ER -